NDC 0409-1144-01 - Verapamil Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1144
- Requested NDC
- 0409-1144-01
- Package NDCs from labels
- 0409-1144-62, 0409-1144-02, 0409-1144-65, 0409-1144-05, 0409-1144-11, 0409-1144-10, 0409-1144-01
- Manufacturer
- Hospira, Inc.
- Effective date
- 2026-07-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Verapamil Hydrochloride Injection, USP | Hospira, Inc. | 2026-07-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Verapamil Hydrochloride Injection, USP | Hospira, Inc. | Pfizer Healthcare India Private Limited | Nitto Avecia Pharma Services, Inc. | 2026-04-29 | HUMAN PRESCRIPTION DRUG LABEL |
| VERAPAMIL HYDROCHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-19 | HUMAN PRESCRIPTION DRUG LABEL |
| VERAPAMIL HCI - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-02-01 | HUMAN PRESCRIPTION DRUG LABEL |
| Verapamil Hydrochloride - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2019-12-16 | HUMAN PRESCRIPTION DRUG LABEL |
| Verapamil Hydrochloride - Cardinal Health | Cardinal Health | 2019-09-13 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1144-02 | Verapamil Hydrochloride | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 24 | |
| 0409-1144-05 | Verapamil Hydrochloride | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 24 | |
| 0409-1144-62 | Verapamil Hydrochloride | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 24 | |
| 0409-1144-65 | Verapamil Hydrochloride | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 24 | |
| 0409-1144-10 | Verapamil Hydrochloride | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 14 | |
| 0409-1144-11 | Verapamil Hydrochloride | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 14 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0409-1144 | VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 22 | Current NDC, Legacy NDC, 4 package rows | 20241109_1c993365-1b62-4524-e781-d307f28f63bc.zip |
| 0409-1144 | VERAPAMIL HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 12 | Current NDC, Legacy NDC, 2 package rows | 20241024_70057a53-ca29-4848-ab3d-5e691e2a14a3.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-1144-01 | ML - Milliliter | 0409-1144 | 1c0cbad9-d3a6-4e81-a12d-bc7278813752 | 1 | 2012-07-24 |
| 0409-1144-02 | ML - Milliliter | 0409-1144 | 2a1dfbca-a12c-41cc-af25-c1d6dd5ebcd6 | 1 | 2012-07-24 |
| 0409-1144-05 | ML - Milliliter | 0409-1144 | 067508cf-4ac4-4905-9b50-eac564de3b98 | 1 | 2012-07-24 |
| 0409-1144-10 | ML - Milliliter | 0409-1144 | 69396de1-9dc4-4aa6-9115-796721a02be3 | 1 | 2018-07-03 |
| 0409-1144-11 | ML - Milliliter | 0409-1144 | 0547e790-5b24-4ff0-9cfd-aa764e9c15c1 | 1 | 2018-07-03 |
| 0409-1144-62 | ML - Milliliter | 0409-1144 | 499e8c34-0c1b-4fb9-9ebc-bf0c7900ee9d | 1 | 2019-07-02 |
| 0409-1144-65 | ML - Milliliter | 0409-1144 | 04b1829a-5f8e-4594-afae-8a316138740a | 1 | 2019-07-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Chloride | SODIUM CHLORIDE | Rising Pharma Holdings, Inc. | 42870188-b1d7-4934-a6c0-310530497dac | 2025-11-07 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Henry Schein, Inc. | d8b8d796-bfba-42af-a859-99d776871558 | 2025-11-07 | Adverse reactions | 451W47IQ8X |
| STERILE WATER | WATER | Henry Schein, Inc. | f4087143-9868-4308-b96c-43657ee8ec28 | 2025-11-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Bacteriostatic Sodium Chloride | SODIUM CHLORIDE | Henry Schein, Inc. | 31188cdf-7bc8-4d78-bfaf-c1dc9f851fd4 | 2025-11-07 | Warnings, Adverse reactions | 451W47IQ8X |
| Verapamil Hydrochloride | VERAPAMIL HYDROCHLORIDE | Henry Schein, Inc. | 9650680c-89ae-451b-aa75-4d34158866e7 | 2025-11-07 | Warnings, Adverse reactions | ANDA075136 V3888OEY5R |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | d3d29c8f-c326-4097-814a-7f4e08c67068 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, AND POTASSIUM CHLORIDE | B. Braun Medical Inc. | 01721071-af03-4894-95c1-10b8bc64b888 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose in Lactated Ringers | DEXTROSE, SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | 190da07e-a616-46e6-b4e5-1c0ba39306e5 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | f6d82772-638c-4584-b9d3-8833669f5963 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | REMEDYREPACK INC. | d7c29dfd-3968-41ac-a081-e670f9bd605c | 2025-11-03 | Warnings, Adverse reactions | V3888OEY5R |
| Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula | CANDIDA ALBICANS, WOOD CREOSOTE, SODIUM CHLORIDE, SULPHUR | TRP Company | 42b6b9b9-a673-0bba-e063-6394a90a8866 | 2025-11-03 | Warnings | 451W47IQ8X |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | ICU Medical Inc. | d8ee14e9-6733-4813-9f21-2b043a5f7188 | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | ICU Medical Inc. | 4555b1bf-6d97-4798-a63d-6d34291c85ce | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Potassium Chloride in Sodium Chloride | SODIUM CHLORIDE AND POTASSIUM CHLORIDE | ICU Medical Inc. | 9dd1c001-73b3-41d4-9a96-61f6ad3a5dc3 | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Chloride | SODIUM CHLORIDE | ICU Medical Inc. | 3cfdeee0-ff14-4341-8396-b11c2a037c60 | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | ICU Medical Inc. | 5f372b75-d7a4-471e-8ac6-290040fc84b0 | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Potassium Chloride in Sodium Chloride | SODIUM CHLORIDE AND POTASSIUM CHLORIDE | ICU Medical Inc. | 243fe8fc-996a-4855-8daf-069628e547c4 | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.